3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Fasting
9
Prostatic Neoplasms
3
Breast Neoplasms
3
Intermittent Fasting
2
Polycystic Ovary Syndrome
1
Ovarian Neoplasms
1
Neoplasms
1
Lymphoma
1
Infertility
1
Glioma
1
Fibrosis
1
Fasting in Malignant Solid Tumors
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Childhood Cancer Survivors
1
Interventions
Cyclophosphamide
25
Rituximab
18
fludarabine phosphate
15
Radiotherapy
13
Methotrexate
13
Peripheral Blood Stem Cell Transplantation
12
Filgrastim
12
Cytarabine
12
Vincristine
11
Melphalan
10
Cyclosporine
10
Busulfan
10
Antilymphocyte Serum
10
Exercise
9
Doxorubicin
9
Prednisone
7
Mycophenolic Acid
7
Magnetic Resonance Spectroscopy
7
Etoposide
7
Early Intervention, Educational
7
Whole-Body Irradiation
6
Surveys and Questionnaires
6
Prednisolone
6
Palliative Care
6
Methods
6
Leucovorin
6
Educational Status
6
Blood Specimen Collection
6
Dexamethasone
5
pegylated granulocyte colony-stimulating factor
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Lymphoma
×
Angptl4 protein, mouse
×
Clear all
NCT06645093
2026-03-10
FasteStudien
University of Oslo
Phase NA
Enrolling by invitation
40 enrolled